Novarad, PenRad extend partnership to boost diagnostic tracking
Novarad will offer PenRad's PenLung automated tracking and reporting system for lung cancer screening, as part of its…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Nov 21
Novarad will offer PenRad's PenLung automated tracking and reporting system for lung cancer screening, as part of its…
29 Nov 21
Eurofins, through Gold Standard Diagnostics Europe, provides the toolset to rapidly identify the variant B.1.1.529
29 Nov 21
The company’s new and enhanced solutions feature an integrated approach across the imaging enterprise focused on critical areas
29 Nov 21
The Aquilion ONE / PRISM Edition integrates artificial intelligence (AI) technology, powered by Altivity (Canon Medical’s bold, new…
26 Nov 21
Lunit is involved in the development of AI-powered diagnostic tools for cancer screening, as well as biomarkers to…
26 Nov 21
Designed to target the ORF1ab gene, the genesig Covid-19 assay holds the potential to identify all known variants…
26 Nov 21
The Prosigna assay is the only breast cancer genomic test that is both CE-IVD marked and recommended by…
26 Nov 21
The new national strategy will enable nasopharyngeal PCR tests to continue as primary diagnostic test, supported other testing…
25 Nov 21
By consolidating machine learning and deep learning technologies, the new AI brand is said to offer enhanced quality…
25 Nov 21
Philips’ Spectral detector CT imaging in the interventional suite will support minimally-invasive procedures in oncology, stroke, and trauma…